What is the in vitro fertilization market size?

The in vitro fertilization market size is approximately USD 17.3 billion as of 2022.

What is the growth forecast for the in vitro fertilization market?

The market is expected to grow at a CAGR of 6.8% from 2023 to 2028.

What are the key drivers of the in vitro fertilization market?

Key drivers include increasing infertility rates and advancing technology.

What are the challenges facing the in vitro fertilization market?

Challenges include high treatment costs and limited insurance coverage.

Which regions are leading the in vitro fertilization market?

North America and Europe are leading the market due to high adoption rates.

Who are the top companies in the in vitro fertilization market?

Top companies include CooperSurgical and Vitrolife, offering innovative solutions.

What future opportunities exist in the in vitro fertilization market?

Future opportunities include expanding into emerging markets and developing new technologies.

How is technology impacting the in vitro fertilization market?

Technology is improving treatment outcomes and increasing accessibility.

What is the regulatory landscape for the in vitro fertilization market?

The regulatory landscape is evolving, with a focus on safety and efficacy.

What is the future outlook for the in vitro fertilization market?

The future outlook is positive, driven by increasing demand and advancing technologies.

What Is the Global in vitro fertilization Market Worth in 2026?

in vitro fertilization by Application (Fertility Clinics and Surgical Centers, Hospital and Research Laboratories, Cryobanks), by Types (Fresh Non-donor, Frozen Non-donor, Fresh Donor, Frozen Donor), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $24500 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $24500 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

in vitro fertilization Market Overview

The in vitro fertilization (IVF) market refers to the industry that provides assisted reproductive technology to help individuals or couples conceive. As the in vitro fertilization market size continues to grow, it is essential to understand the growth outlook and market forecast to navigate the industry expansion. The scope of this market encompasses various synonyms, including assisted reproductive technology, fertility treatment, and infertility services. According to recent estimates, the current in vitro fertilization market size is approximately $24.6 billion. The growth forecast indicates a compound annual growth rate (CAGR) of 7.4% from 2026 to 2033, driven by macro drivers such as increasing infertility rates, advancements in technology, and growing awareness about fertility treatments.

Loading chart…

Key forces shaping the industry include technology shifts, such as the development of more effective fertility treatments, regulations, such as changes in laws and guidelines governing IVF, and consumer behavior, such as increasing demand for fertility services. The largest region in the IVF market is North America, while the fastest-growing region is Asia-Pacific. The in vitro fertilization market is expected to continue its growth outlook due to these driving factors, making it an attractive industry for investors and stakeholders.

Report Overview

Report Attribute	Details
Market size value in 2025	24.50 billion
Revenue forecast in 2033	53.29 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; Cook Medical; Merck KGaA; Vitrolife; Ovascience; CooperSurgical; EMD Serono; Genea; Rocket Medical; Fertility Focus
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The in vitro fertilization market is poised for significant growth, driven by various factors. The market dynamics are influenced by a combination of growth drivers, restraints, opportunities, and challenges that shape the industry's trajectory.

Growth Drivers2 items

Advances in in vitro fertilization technologies, such as preimplantation genetic testing and time-lapse embryo imaging, have improved success rates and increased demand for these services, contributing to the growth of the in vitro fertilization market size

Rising awareness about in vitro fertilization and increasing acceptance of assisted reproductive technologies have expanded the patient pool, further fueling the market's growth forecast

Restraints2 items

High costs associated with in vitro fertilization procedures and limited insurance coverage in many countries hinder access to these services, restricting the in vitro fertilization market size

Stringent regulatory frameworks and varying laws governing in vitro fertilization practices across different regions can create uncertainty and challenges for market players, affecting the overall growth forecast

Opportunities2 items

Emerging markets in Asia-Pacific and Latin America offer significant opportunities for growth, driven by increasing demand for in vitro fertilization services and improving healthcare infrastructure, which is expected to contribute to the in vitro fertilization market expansion

The development of more affordable and effective in vitro fertilization treatments, such as in vitro maturation and in vitro fertilization with minimal stimulation, can help expand the patient base and drive market growth, influencing the in vitro fertilization market size

Challenges2 items

The in vitro fertilization market faces challenges related to the emotional and psychological aspects of infertility, requiring market players to invest in patient support services and counseling, which can impact the growth forecast

The industry must also address concerns regarding the ethical and social implications of in vitro fertilization, such as egg and sperm donation, surrogacy, and genetic testing, to maintain public trust and support, essential for the in vitro fertilization market growth

Market Segmentation

Loading chart…

The in vitro fertilization segmentation can be categorized based on application, which includes various subtypes such as fertility clinics, hospitals, and research institutions. The application segment contributes to the overall in vitro fertilization market size by providing a comprehensive overview of the different areas where in vitro fertilization services are utilized. Fertility clinics account for the largest share of the market, as they are the primary providers of in vitro fertilization services.

The types segment of the in vitro fertilization market includes various subtypes, such as intracytoplasmic sperm injection (ICSI), in vitro fertilization (IVF), and donor egg IVF. Each subtype has its own unique characteristics and contributes to the overall market size. Intracytoplasmic sperm injection (ICSI) is a specialized type of IVF that involves the injection of a single sperm into an egg, while in vitro fertilization (IVF) involves the fertilization of an egg with sperm outside the body. Understanding the different types of in vitro fertilization services is crucial for market taxonomy and analyzing the overall market trends.

in vitro fertilization Segmentation Breakdown9 items

Application

Fertility Clinics and Surgical Centers

Hospital and Research Laboratories

Cryobanks

Types

Fresh Non-donor

Frozen Non-donor

Fresh Donor

Frozen Donor

Regional Insights

Loading chart…

The in vitro fertilization market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 35% of the global market, and Asia Pacific being the fastest-growing region. The key drivers for North America include adoption of advanced fertility treatments, favorable policies, and significant investments in healthcare infrastructure. In Europe, the key drivers are demographics, with an increasing aging population, ecosystem maturity, and a high demand for fertility services.

In Asia Pacific, the key drivers are infrastructure development, increasing awareness about fertility treatments, and government initiatives to promote family planning. Latin America's growth is driven by increasing access to fertility services, growing demand for in vitro fertilization, and improving healthcare infrastructure. The Middle East & Africa region is driven by government support, growing awareness about fertility treatments, and increasing investments in healthcare. These factors will contribute to the regional forecast and shape the in vitro fertilization market in the coming years.

Key Regional Drivers5 items

North America: adoption, policies, investments

Europe: demographics, ecosystem maturity, demand

Asia Pacific: infrastructure, awareness, government initiatives

Latin America: access, demand, infrastructure

Middle East & Africa: government support, awareness, investments

Competitive Landscape

The in vitro fertilization market is moderately consolidated, driven by a mix of global players and local/regional companies. The in vitro fertilization competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and regulatory approvals, while local companies concentrate on pricing and distribution.

Companies in this market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are adapting their strategies to address these challenges.

Thermo Fisher Scientific: regional expansion

Cook Medical: premium pricing

Merck KGaA: innovation pipeline

Vitrolife: local manufacturing

Ovascience: OEM tie-ups

CooperSurgical: vertical integration

Key in vitro fertilization Companies10 items

Thermo Fisher Scientific

Cook Medical

Merck KGaA

Vitrolife

Ovascience

CooperSurgical

EMD Serono

Genea

Rocket Medical

Fertility Focus

Market Ecosystem

The in vitro fertilization ecosystem spans upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured as technology providers supply essential components, integrators develop and manufacture products, channels distribute these products to end users, and end users ultimately receive in vitro fertilization services. Understanding the in vitro fertilization ecosystem is crucial for conducting a comprehensive value chain analysis.

Raw material suppliers — provide biological and chemical materials

Technology providers — develop fertility treatment technologies

OEMs/manufacturers — produce medical equipment and devices

Distributors/channel partners — supply products to fertility clinics

Service providers/after-sales — offer maintenance and support services

Regulators/standards bodies — establish and enforce industry standards

End users/buyers — receive in vitro fertilization services

Control points in the in vitro fertilization ecosystem are primarily held by regulators and standards bodies, as they influence adoption through approvals and standards. Dependency risks arise from input constraints, such as the availability of high-quality biological materials, and from regulatory approvals. Switching costs and partnerships are significant, as fertility clinics often invest heavily in specific technologies and services. The ecosystem differs by region, with varying regulatory environments and availability of services, highlighting the need for a nuanced understanding of the in vitro fertilization ecosystem.

Recent Industry Insights

The in vitro fertilization industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between fertility clinics and technology companies, have aimed to improve the efficiency and accessibility of in vitro fertilization services. Additionally, there have been notable mergers and acquisitions, with companies expanding their presence in the market through strategic acquisitions. Product and technology launches have also been a key focus area, with the introduction of advanced embryo screening techniques and improved cryopreservation methods.

Furthermore, regulatory changes have played a crucial role in shaping the in vitro fertilization industry trends. The shift in consumer trends towards increased awareness and acceptance of infertility treatments has also driven growth in the market. Funding rounds and expansions have enabled companies to invest in research and development, leading to innovative solutions and improved outcomes for patients. Overall, these developments have contributed to the growth and evolution of the in vitro fertilization industry, with a focus on improving accessibility, efficiency, and success rates.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the in vitro fertilization market. The market attractiveness is moderate, driven by increasing demand for fertility treatments and advancements in technology. The competitive intensity is high, with several major players competing for market share. Looking at the in vitro fertilization market outlook, the long-term prospects are promising, with the market expected to grow significantly over the next five years.

The innovation landscape is rapidly evolving, with new technologies and treatments being developed to improve success rates and patient outcomes. However, the demand-supply balance is a key concern, with a shortage of qualified professionals and limited access to fertility treatments in some regions. Key risk factors include regulatory changes, economic uncertainty, and the potential for market saturation. Despite these challenges, the in vitro fertilization market is expected to continue growing, driven by increasing awareness and demand for fertility treatments.

11 items

1. Executive Summary

2. in vitro fertilization Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global in vitro fertilization Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global in vitro fertilization Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Fertility Clinics and Surgical Centers

6.1.2. Hospital and Research Laboratories

6.1.3. Cryobanks

6.2. Global in vitro fertilization Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Fresh Non-donor

6.2.2. Frozen Non-donor

6.2.3. Fresh Donor

6.2.4. Frozen Donor

6.3. Global in vitro fertilization Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global in vitro fertilization Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global in vitro fertilization Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global in vitro fertilization Market Competition by Key Manufacturers

8.1. Global in vitro fertilization Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global in vitro fertilization: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Thermo Fisher Scientific

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Cook Medical

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Merck KGaA

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Vitrolife

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Ovascience

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. CooperSurgical

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. EMD Serono

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Genea

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Rocket Medical

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Fertility Focus

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global in vitro fertilization Market

Figure 4: Global in vitro fertilization Market: Drivers

Figure 5: Global in vitro fertilization Market: Challenges

Figure 6: Global in vitro fertilization Market: Trends

Figure 7: Global in vitro fertilization Market: Opportunity

Figure 8: Global in vitro fertilization Market: Restraint

Figure 9: Global in vitro fertilization Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global in vitro fertilization Market Value (USD Million) By Region

Figure 15: Global in vitro fertilization Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global in vitro fertilization Market Value (USD Million) By Region

Figure 23: Global in vitro fertilization Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global in vitro fertilization Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global in vitro fertilization Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global in vitro fertilization Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global in vitro fertilization Market Value (USD Million) By Region

Table 10: Global in vitro fertilization Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global in vitro fertilization Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global in vitro fertilization Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global in vitro fertilization Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Thermo Fisher Scientific Basic Information And Sales Area

Table 31: Thermo Fisher Scientific. Products Portfolio

Table 32: Cook Medical Basic Information And Sales Area

Table 33: Cook Medical. Products Portfolio

Table 34: Merck KGaA Basic Information And Sales Area

Table 35: Merck KGaA. Products Portfolio

Table 36: Vitrolife Basic Information And Sales Area

Table 37: Vitrolife. Products Portfolio

Table 38: Ovascience Basic Information And Sales Area

Table 39: Ovascience. Products Portfolio

Table 40: CooperSurgical Basic Information And Sales Area

Table 41: CooperSurgical. Products Portfolio

Table 42: EMD Serono Basic Information And Sales Area

Table 43: EMD Serono. Products Portfolio

Table 44: Genea Basic Information And Sales Area

Table 45: Genea. Products Portfolio

Table 46: Rocket Medical Basic Information And Sales Area

Table 47: Rocket Medical. Products Portfolio

Table 48: Fertility Focus Basic Information And Sales Area

Table 49: Fertility Focus. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global in vitro fertilization Market Value (USD Million) By Region

Table 55: Global in vitro fertilization Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

in vitro fertilization Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	24.50 billion
Revenue forecast in 2033	53.29 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; Cook Medical; Merck KGaA; Vitrolife; Ovascience; CooperSurgical; EMD Serono; Genea; Rocket Medical; Fertility Focus
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising awareness about in vitro fertilization and increasing acceptance of assisted reproductive technologies have expanded the patient pool, further fueling the market's growth forecast

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

in vitro fertilization Segmentation Breakdown9 items

Application

Fertility Clinics and Surgical Centers

Hospital and Research Laboratories

Cryobanks

Types

Fresh Non-donor

Frozen Non-donor

Fresh Donor

Frozen Donor

Regional Insights

Loading chart…

Key Regional Drivers5 items

North America: adoption, policies, investments

Europe: demographics, ecosystem maturity, demand

Asia Pacific: infrastructure, awareness, government initiatives

Latin America: access, demand, infrastructure

Middle East & Africa: government support, awareness, investments

Competitive Landscape

Thermo Fisher Scientific: regional expansion

Cook Medical: premium pricing

Merck KGaA: innovation pipeline

Vitrolife: local manufacturing

Ovascience: OEM tie-ups

CooperSurgical: vertical integration

Key in vitro fertilization Companies10 items

Thermo Fisher Scientific

Cook Medical

Merck KGaA

Vitrolife

Ovascience

CooperSurgical

EMD Serono

Genea

Rocket Medical

Fertility Focus

Market Ecosystem

Raw material suppliers — provide biological and chemical materials

Technology providers — develop fertility treatment technologies

OEMs/manufacturers — produce medical equipment and devices

Distributors/channel partners — supply products to fertility clinics

Service providers/after-sales — offer maintenance and support services

Regulators/standards bodies — establish and enforce industry standards

End users/buyers — receive in vitro fertilization services

Recent Industry Insights

Analyst Overview

Table of Contents